Syros Pharmaceuticals Inc...

NASDAQ: SYRS · Real-Time Price · USD
0.03
0.00 (19.52%)
At close: Jun 09, 2025, 3:26 PM

Syros Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
139.53M 167.47M 92.3M
Short-Term Investments
n/a 34.84M 38.07M
Long-Term Investments
n/a 3.09M 13.04M
Other Long-Term Assets
3.71M 5.35M 6.03M
Receivables
n/a 1.69M 2.98M
Inventory
n/a n/a n/a
Other Current Assets
5.45M 7.39M n/a
Total Current Assets
144.98M 211.39M 136.59M
Property-Plant & Equipment
19.48M 24.66M 27.29M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
23.19M 33.09M 46.35M
Total Assets
168.17M 244.49M 182.94M
Account Payables
11.54M 6.41M 3.69M
Deferred Revenue
n/a 4.33M 10.18M
Short-Term Debt
6.67M 2.07M 2.01M
Other Current Liabilities
6.99M 7.37M 7.27M
Total Current Liabilities
36.68M 30.78M 31.51M
Long-Term Debt
34.56M 40.65M 40.26M
Other Long-Term Liabilities
61.75M 24.47M 3.03M
Total Long-Term Liabilities
114.83M 85.97M 66.21M
Total Liabilities
151.51M 116.75M 97.72M
Total Debt
62.08M 63.57M 65.19M
Book Value
n/a n/a n/a
Book Value Per Share
n/a n/a n/a
Common Stock
26K 20K 61K
Retained Earnings
-722.81M -558.23M -463.58M
Comprehensive Income
n/a 102K -79K
Shareholders Equity
16.66M 127.74M 85.22M
Total Investments
2.12M 34.84M 51.1M